Fractional Flow Reserve Measurements Are Used For Measuring Blood Pressure and Flow in Coronary Arteries and Are Performed Under Sedation

Fractional Flow Reserve
Fractional Flow Reserve

The Fractional Flow Reserve is a measurement of blood pressure and flows in a coronary artery. It is performed with the help of a guide wire through a standard diagnostic catheter during a coronary angiogram. It is used to determine if angioplasty or stenting is needed to open up a coronary artery and increase blood flow to the heart. If a patient has a high FFR, the procedure should be considered.

Several studies have compared the Fractional Flow Reserve with angiography. While invasive coronary angiography is the gold standard for functional assessment of coronary artery disease, noninvasive fractional flow reserve has emerged as an effective adjunct to the invasive procedure. Furthermore, it has shown high diagnostic accuracy, may improve patient outcomes, reduce health care costs, and increase patient quality of life. Current approaches include full-order and reduced-order computational fluid-dynamic models, as well as artificial intelligence-based deep machine learning algorithms.

A new test called FFR was developed to determine the functional importance of coronary stenosis. The FFR is a quantitative measurement of coronary artery pressure. It is used to identify patients who will benefit from coronary revascularization. However, it is important to understand that the FFR does not measure the actual blood flow within the coronary artery. The FFR does not account for the pressure of the aortic valve. The Fractional Flow Reserve Market measurement is used to determine the severity of coronary stenosis. It helps to determine treatment options by using antegrade and collateral flow. FFR measurements are accurate even in patients with chronic myocardial infarction. It also saves patients money by reducing the use of contrast media and other diagnostic procedures. And, FFR is also a valuable tool for identifying patients with intermediate or high stenosis.

A Fractional Flow Reserve measurement is performed under sedation by a physician. In the procedure, the patient lies flat on the operating table while the physician inserts a thin guide wire. He then injects a medicine into the blood vessel. This increases blood flow. The flow and pressure are measured with a monitor and the doctor can then see the results. In November 2021, MMCSC (Monmouth Medical Center Southern Campus) announced the availability of a technology called FFR-CT (Fractional Flow Reserve Computed Tomography, which evaluates the blood flow through the arteries to determine presence of blockages and their location.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more